Ignite Creation Date:
2024-05-05 @ 11:57 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00184002
Status:
COMPLETED
Last Update Posted:
2017-08-10
First Post:
2005-09-12
Brief Title:
Doxorubicin Doxil Combined With Rituxan Cyclophosphamide Vincristine and Prednisone in Newly Diagnosed Aggressive Non-Hodgkins Lymphomas
Sponsor:
University of Southern California
Organization:
University of Southern California
Organization Data
Organization:
University of Southern California
Class:
OTHER
Study ID:
13NHL-02-3
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Southern California
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Ortho Biotech Inc | INDUSTRY |